• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障渗透:控制被动扩散的分子参数。

Blood-brain barrier permeation: molecular parameters governing passive diffusion.

作者信息

Fischer H, Gottschlich R, Seelig A

机构信息

Department of Biophysical Chemistry, Biocenter of the University of Basel, Klingelbergstr, 70, CH-4056 Basel, Switzerland.

出版信息

J Membr Biol. 1998 Oct 1;165(3):201-11. doi: 10.1007/s002329900434.

DOI:10.1007/s002329900434
PMID:9767674
Abstract

53 compounds with clinically established ability to cross or not to cross the blood-brain barrier by passive diffusion were characterized by means of surface activity measurements in terms of three parameters, i.e., the air-water partition coefficient, Kaw, the critical micelle concentration, CMCD, and the cross-sectional area, AD. A three-dimensional plot in which the surface area, AD, is plotted as a function of K-1aw and CMCD shows essentially three groups of compounds: (i) very hydrophobic compounds with large air-water partition coefficients and large cross-sectional areas, AD > 80 A2 which do not cross the blood-brain barrier, (ii) compounds with lower air-water partition coefficients and an average cross-sectional area, AD congruent with 50 A2 which easily cross the blood-brain barrier, and (iii) hydrophilic compounds with low air-water partition coefficients (AD < 50 A2) which cross the blood-brain barrier only if applied at high concentrations. It was shown that the lipid membrane-water partition coefficient, Klw, measured previously, can be correlated with the air-water partition coefficient if the additional work against the internal lateral bilayer pressure, pibi = 34 +/- 4 mN/m is taken into account. The partitioning into anisotropic lipid membranes decreases exponentially with increasing cross-sectional areas, AD, according to Klw = const. Kaw exp(-ADpibi/kT) where kT is the thermal energy. The cross-sectional area of the molecule oriented at a hydrophilic-hydrophobic interface is thus the main determinant for membrane permeation provided the molecule is surface active and has a pKa > 4 for acids and a pKa < 10 for bases.

摘要

通过被动扩散具有临床确定的能够穿过或不能穿过血脑屏障能力的53种化合物,通过表面活性测量以三个参数进行表征,即气-水分配系数Kaw、临界胶束浓度CMCD和截面积AD。一个三维图,其中将表面积AD作为Kaw-1和CMCD的函数绘制,显示出基本上三组化合物:(i) 具有大气-水分配系数和大截面积(AD>80 Å2)的非常疏水的化合物,它们不穿过血脑屏障;(ii) 具有较低气-水分配系数和平均截面积(AD≈50 Å2)的化合物,它们容易穿过血脑屏障;以及(iii) 具有低气-水分配系数(AD<50 Å2)的亲水性化合物,它们仅在高浓度下应用时才穿过血脑屏障。结果表明,如果考虑到对抗内部横向双层压力pibi = 34±4 mN/m的额外功,则先前测量的脂质膜-水分配系数K1w可以与气-水分配系数相关。根据K1w = const·Kaw exp(-ADpibi/kT),其中kT是热能,进入各向异性脂质膜的分配随截面积AD的增加呈指数下降。因此,对于酸pKa>4且对于碱pKa<10的表面活性分子,在亲水-疏水界面处取向的分子的截面积是膜渗透的主要决定因素。

相似文献

1
Blood-brain barrier permeation: molecular parameters governing passive diffusion.血脑屏障渗透:控制被动扩散的分子参数。
J Membr Biol. 1998 Oct 1;165(3):201-11. doi: 10.1007/s002329900434.
2
In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter.以计算得到的分子横截面积为主要参数进行血脑屏障通透性的计算机模拟预测。
J Chem Inf Model. 2006 Nov-Dec;46(6):2638-50. doi: 10.1021/ci0600814.
3
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Eur J Pharm Sci. 2000 Nov;12(1):31-40. doi: 10.1016/s0928-0987(00)00177-9.
4
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.用于预测血脑屏障通透性的药物表面活性分析
J Med Chem. 2004 Mar 25;47(7):1783-8. doi: 10.1021/jm0309001.
5
A method to determine the ability of drugs to diffuse through the blood-brain barrier.一种确定药物透过血脑屏障能力的方法。
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):68-72. doi: 10.1073/pnas.91.1.68.
6
Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.IAM-HPLC 指数中酸性药物与膜磷脂之间的亲脂性和极性相互作用力:它们在膜分配中的作用及与 BBB 渗透数据的关系。
J Pharm Biomed Anal. 2013 Mar 5;75:165-72. doi: 10.1016/j.jpba.2012.11.034. Epub 2012 Dec 1.
7
Halogenation of drugs enhances membrane binding and permeation.药物的卤化作用增强了膜结合及渗透能力。
Chembiochem. 2004 May 3;5(5):676-84. doi: 10.1002/cbic.200400017.
8
Prediction of micelle/water and liposome/water partition coefficients based on molecular dynamics simulations, COSMO-RS, and COSMOmic.基于分子动力学模拟、COSMO-RS 和 COSMOmic 预测胶束/水和脂质体/水分配系数。
Langmuir. 2013 Mar 19;29(11):3527-37. doi: 10.1021/la305035b. Epub 2013 Mar 8.
9
Factors involved in the absence of sedative effects by the second-generation antihistamines.第二代抗组胺药无镇静作用所涉及的因素。
Allergy. 2000;55 Suppl 60:5-10. doi: 10.1034/j.1398-9995.2000.055supp60005.x.
10
Kinetics of permeation of nucleotide through oil/water interface in the interaction of nucleotide with octadecylamine and dodecyl guanidine.核苷酸与十八胺和十二烷基胍相互作用时核苷酸通过油/水界面的渗透动力学。
Biochim Biophys Acta. 1976 Sep 21;448(1):155-66. doi: 10.1016/0005-2736(76)90084-5.

引用本文的文献

1
Advanced P407/Tw80/βCD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson's Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation.用于帕金森病鼻脑递送的基于泊洛沙姆407/吐温80/β-环糊精的新型盐酸罗匹尼罗鼻用粉剂:制备及全面的体外和离体评价
AAPS J. 2025 Sep 18;27(6):143. doi: 10.1208/s12248-025-01128-4.
2
Nanotherapy of Glioblastoma-Where Hope Grows.胶质母细胞瘤的纳米疗法——希望之所系
Int J Mol Sci. 2025 Feb 20;26(5):1814. doi: 10.3390/ijms26051814.
3
Advancements in nanotheranostics for glioma therapy.
用于神经胶质瘤治疗的纳米诊疗学进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2587-2608. doi: 10.1007/s00210-024-03559-w. Epub 2024 Oct 31.
4
Unveiling the Mysteries of the Blood-brain Barrier: The Problem of the Brain/spinal Pharmacotherapy.揭开血脑屏障的奥秘:脑/脊髓药物治疗问题
Cent Nerv Syst Agents Med Chem. 2025;25(2):91-108. doi: 10.2174/0118715249297247240813104929.
5
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.评估用于杜氏肌营养不良症治疗的熊去氧胆酸共轭寡核苷酸肠道渗透性的体外研究
Pharmaceutics. 2024 Aug 1;16(8):1023. doi: 10.3390/pharmaceutics16081023.
6
Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.小儿大脑半球高级别胶质瘤和 H3.3-G34 突变:对生物学特征和新治疗策略的文献回顾。
Genes (Basel). 2024 Aug 6;15(8):1038. doi: 10.3390/genes15081038.
7
Dealing with the complexity of conjugated and self-assembled polymer-nanostructures using field-flow fractionation.使用场流分级法处理共轭和自组装聚合物纳米结构的复杂性。
Anal Sci Adv. 2021 Mar 5;2(3-4):95-108. doi: 10.1002/ansa.202100008. eCollection 2021 Apr.
8
Astragaloside IV as a Memory-Enhancing Agent: In Silico Studies with In Vivo Analysis and Post Mortem ADME-Tox Profiling in Mice.黄芪甲苷作为一种增强记忆的药物:体内分析和死后 ADME-Tox 分析在小鼠中的计算机模拟研究。
Int J Mol Sci. 2024 Apr 4;25(7):4021. doi: 10.3390/ijms25074021.
9
Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis.胃肠道和大脑屏障:解锁微生物群-肠道-大脑轴上的沟通之门。
Nat Rev Gastroenterol Hepatol. 2024 Apr;21(4):222-247. doi: 10.1038/s41575-023-00890-0. Epub 2024 Feb 14.
10
Biomimetic Synthesis and Chemical Proteomics Reveal the Mechanism of Action and Functional Targets of Phloroglucinol Meroterpenoids.仿生合成与化学蛋白质组学揭示间苯三酚倍半萜类化合物的作用机制和功能靶点。
J Am Chem Soc. 2024 Jan 31;146(4):2524-2548. doi: 10.1021/jacs.3c10741. Epub 2024 Jan 17.